Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Sandra Peterson To Join Johnson & Johnson On Dec. 1 As Group Worldwide Chairman

RELATED NEWS
Trade JNJ now with 

Johnson & Johnson (JNJ: Quote) announced Sandra Peterson will join it on December 1, as Group Worldwide Chairman and member of Executive Committee. Peterson will have responsibility for the Consumer Group of Companies, Information Technology, and Global Supply Chain. She will be based at Johnson & Johnson headquarters in New Brunswick, New Jersey.

Sandra Peterson is currently the Chairman and Chief Executive Officer of Bayer CropScience AG, based in Europe. Peterson has held her current role at Bayer since 2010. Previously, she was president and chief executive officer of Bayer Medical Care and president of Bayer HealthCare AG's Diabetes Care Division.

Click here to receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.